Marble Wealth’s AstraZeneca AZN Stock Holding History

Marble Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311K	Hold	1,643	–	–	0.05%	189
2026 Q1	$324K	Sell	1,643 -28	-2%	-$5.4K	0.06%	173
2025 Q4	$307K	Buy	+1,671	New	+$293K	0.04%	226

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marble Wealth's AZN Position: Q2 2026 in Review

Marble Wealth held its AstraZeneca (AZN) position steady in Q2 2026 at 1,643 shares worth $311K. The position accounts for 0.05% of the portfolio, ranked #189.

Marble Wealth first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $324K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Marble Wealth held 1,643 shares of AstraZeneca worth $311K as of Q2 2026.
Marble Wealth left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.05% of Marble Wealth's portfolio in Q2 2026, its #189 holding.
Marble Wealth first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
Marble Wealth's AstraZeneca position peaked at $324K in Q1 2026.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Marble Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.